Tiziana life sciences to present at biotech showcase conference in san francisco, january 8-10, 2024

New york, jan. 05, 2024 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its chief operating officer and chief medical officer, matthew davis, md, rph, will present at biotech showcase, san francisco, january 8-10, 2024.
TLSA Ratings Summary
TLSA Quant Ranking